Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis

BACKGROUND AND AIMS: In the last decade, several second-line therapies followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC) have been reported. But the outcomes were different from each other. This meta-analysis aimed to evaluate the efficacy and safety of the second-line t...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Limin, Liao, Haotian, Yuan, Kefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666373/
https://www.ncbi.nlm.nih.gov/pubmed/34966650
http://dx.doi.org/10.14218/JCTH.2021.00054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666373/
https://www.ncbi.nlm.nih.gov/pubmed/34966650
http://dx.doi.org/10.14218/JCTH.2021.00054

Ejemplares similares